Multiple, recurrent, refractory vascular malformations as the primary presenting feature of a PTEN mutation

Pediatric Dermatology

Volumn 28, Issue 4, 2011, Pages 466-467

  Sharabi, Safa E ^a   Koshy, John C ^a   Hollier Jr , Larry H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTERIOVENOUS MALFORMATION; CASE REPORT; CHILD; CLINICAL FEATURE; CONGENITAL TUMOR; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; ULTRASOUND;

ARTERIOVENOUS MALFORMATIONS; CHILD, PRESCHOOL; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; MALE; MUTATION; PTEN PHOSPHOHYDROLASE;

EID: 79960789200     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2010.01298.x     Document Type: Review

References (4)

1. Eng C,. Constipation, polyps, or cancer? Let PTEN predict your future. Am J Med Genet 2003; 112: 315-322. (Pubitemid 37259571)
2. Eng C,. PTEN: one gene, many syndromes. Hum Mutat 2003; 22: 183-198. (Pubitemid 37071635)
3. Tan WH, Baris HN, Burrows PE, et al., The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet 2007; 44: 594-602. (Pubitemid 47441769)
4. Hamada K, Sasaki T, Koni PA,. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 2005; 19: 2054-2065. (Pubitemid 41247962)